Event guide: 8th Neuroimmunology Drug Development Summit 2026

	Immunology
	The latest immunology news from News Medical

The 8th Neuroimmunology Drug Development Summit 2026 is a flagship event for companies advancing therapies at the intersection of neuroscience and immunology.

This guide covers emerging targets, translational models, and clinical trial learnings across MS, neuroinflammation, and neurodegenerative disease pipelines.

Download Your Copy

			AI in Vaccine Development: How Machine Learning is Speeding Up Discovery What if vaccine development didn’t have to take a decade? This piece looks at how AI is helping scientists ask better questions, test smarter, and respond faster.

			High-dose flu shots lower hospitalization risk in older adults High-dose influenza vaccines may lower serious hospitalization rates in older adults, particularly those with diabetes, according to a recent Danish trial.

	Antibody-producing plasma cells shape effectiveness of PD-1 immunotherapy Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why some cancer patients benefit from immunotherapy while others do not.

	Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to accurately identify cancer spread.

	Single-dose HIV vaccine candidate induces neutralizing antibodies Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates.

	Gut microbial butyrate enhances mucosal vaccine antibody responses A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing how butyrate-a short-chain fatty acid produced by gut commensal bacteria-enhances T follicular helper (Tfh) cell activity to promote antibody production and strengthen mucosal vaccine efficacy.

	Rigid Protein Molecular Rulers Enable Precise Control of Antibody Conformation By extending a naturally rigid bacterial protein by 50% while preserving geometry and stability, the study introduces protein-based "molecular rulers" that could probe antibody shape, limit unwanted motion, and support safer, more effective antibody drug design.

	Lower IgG Hinge Controls Antibody Assembly and Immune Function The lower hinge of immunoglobulin G (IgG), an overlooked part of the antibody, acts as a structural and functional control hub, according to a study by researchers at Science Tokyo.

	Machine Learning Model Accelerates Manufacturing Timeline of Monoclonal Antibodies As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026